Browse by Title

Type here to filter the list

U
Unique Model Informed Drug Development Opportunities with PROTAC Protein Degrader
Favorite

Eric Masson, PharmD – Arvinas ### 2363743###Speaker###SVP, Early Clinical Development###Arvinas###
Speaker: Eric Masson, PharmD – Arvinas
###
Untangling Cause-and-Effect for Oncology Dose Selection: Exposure-Response Confounding with Small Molecules
Favorite

Youwei Bi, PhD – FDA, MD ### 2489375###Speaker###Team Lead###FDA, MD###
Speaker: Youwei Bi, PhD – FDA, MD
### @@@ Da Zhang ### 2514036###Speaker#########
Speaker: Da Zhang
###
Use of AI/ML to Support New Drug Development and Enhance Patient Care
Favorite

Hao Zhu, PhD – ISoP ### 2360688###Speaker###ISoP Board Member###ISoP###
Speaker: Hao Zhu, PhD – ISoP
###
Use of quantitative tools to facilitate TCE development—CRS and beyond
Favorite

Xiling Jiang, PhD – US FDA ### 2380201###Speaker###Master Clinical Pharmacologist###US FDA###
Speaker: Xiling Jiang, PhD – US FDA
###
User-Friendly Tools for Population PK and PBPK Modeling
Favorite

Robert R. Bies, Pharm.D. PhD FISoP – Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo ### 2360705###Speaker###Professor of Pharmaceutical Sciences, Associate Dean of Graduate Studies, School of Pharmacy###Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo###
Speaker: Robert R. Bies, Pharm.D. PhD FISoP – Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
###
Using machine learning and multiomics to predict the pharmacokinetics of immunosuppressants and clinical outcomes in renal transplant patients
Favorite

Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy ### 2408503###Speaker###Professor###University of Michigan College of Pharmacy###
Speaker: Hao-Jie Zhu, PhD – University of Michigan College of Pharmacy
###
Utilization of Real-World Data in Clinical Pharmacology – Regulatory Perspectives
Favorite

Lixia Zhang, PhD – FDA ### 2413382###Speaker###Staff Fellow###FDA###
Speaker: Lixia Zhang, PhD – FDA
###
Utilizing platform QSP models for later phase trial design and dose selection
Favorite

Brian Schmidt ### 2407942###Speaker#########
Speaker: Brian Schmidt
###